Exploring the chemogenomic knowledge space with annotated chemical libraries

Current Opinion in Chemical Biology

Volumn 8, Issue 4, 2004, Pages 412-417

  Savchuk, Nikolay P ^a   Balakin, Konstantin V ^a   Tkachenko, Sergey E ^a  

^a CHEMDIV INC   (United States)

Author keywords

absorption, distribution, metabolism, excretion; ADME; G protein coupled receptor; GPCR; National Cancer Institute; NCI

Indexed keywords

CHEMICAL GENETICS; CHEMOGENOMICS; DATA BASE; DRUG DESIGN; DRUG TARGETING; GENE; GENE FUNCTION; GENE LIBRARY; GENE MAPPING; GENOMICS; MEDICAL RESEARCH; REVIEW; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

COMBINATORIAL CHEMISTRY TECHNIQUES; COMPUTER SIMULATION; DATABASES, FACTUAL; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; LIGANDS;

EID: 3342907009     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2004.06.003     Document Type: Review

References (44)

1. Agrafiotis D.K., Lobanov V.S., Salemme F.R. Combinatorial informatics in the post-genomics era. Nat Rev Drug Discov. 1:2002;337-346
2. Salemme F.R. Chemical genomics as an emerging paradigm for postgenomic drug discovery. Pharmacogenomics. 4:2003;1-11
3. Jacoby E., Schuffenhauer A., Floersheim P. Chemogenomics knowledge-based strategies in drug discovery. Drug News Perspect. 16:2003;93-102 A useful survey of current chemogenomics knowledge-based strategies for drug discovery.
4. Weinstein J.N., Myers T.G., O'Connor P.M., Friend S.H., Fornace A.J. Jr., Kohn K.W., Fojo T., Bates S.E., Rubinstein L.V., Anderson N.L., et al. An information-intensive approach to the molecular pharmacology of cancer. Science. 275:1997;343-349
5. Blower P.E., Yang C., Fligner M.A., Verducci J.S., Yu L., Richman S., Weinstein J.N. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J. 2:2002;259-271
6. Rabow A.A., Shoemaker R.H., Sausville E.A., Covell D.G. Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities. J Med Chem. 45:2002;818-840
7. Wallqvist A., Rabow A.A., Shoemaker R.H., Sausville E.A., Covell D.G. Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology. Mol Cancer Ther. 1:2002;311-320
8. Root D.E., Flaherty S.P., Kelley B.P., Stockwell B.R. Biological mechanism profiling using an annotated compound library. Chem Biol. 10:2003;881-892 The authors demonstrate an approach to identification of new disease-associated targets using an annotated library.
9. Frye S.V. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era. Chem Biol. 6:1999;R3-R7
10. Koch M.A., Breinbauer R., Waldmann H. Protein structure similarity as guiding principle for combinatorial library design. Biol Chem. 384:2003;1265-1272
11. Horvath D., Jeandenans C. Neighborhood behavior of in silico structural spaces with respect to in vitro activity spaces - a novel understanding of the molecular similarity principle in the context of multiple receptor binding profiles. J Chem Inf Comput Sci. 43:2003;680-690
12. Schuffenhauer A., Zimmermann J., Stoop R., van der Vyver J.J., Lecchini S., Jacoby E. An ontology for pharmaceutical ligands and its application for in silico screening and library design. J Chem Inf Comput Sci. 42:2002;947-955
13. Schuffenhauer A., Floersheim P., Acklin P., Jacoby E. Similarity metrics for ligands reflecting the similarity of the target proteins. J Chem Inf Comput Sci. 43:2003;391-405 A good example illustrating the practical approach developed by scientists at Novartis for the homology-based design of target-specific libraries.
14. Greenbaum D.C., Arnold W.D., Lu F., Hayrapetian L., Baruch A., Krumrine J., Toba S., Chehade K., Bromme D., Kuntz I.D., Bogyo M. Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem Biol. 9:2002;1085-1094
15. Vieth M., Higgs R.E., Robertson D.H., Shapiro M., Gragg E.A., Hemmerle H. Kinomics - structural biology and chemogenomics of kinase inhibitors and targets. Biochim Biophys Acta. 1697:2004;243-257 An article describing a practical approach developed by scientists at Lilly for collection and exploration of chemical and biological data about kinase inhibitors and targets.
16. Vieth M., Brooks H.B., Hamdouchi C., McMillen W., Sawyer J.S., Yingling J.M., Zhang F. Combining medicinal chemistry with chemogenomic and computer-aided structure-based design in development of novel kinase inhibitors. Cell Mol Biol Lett. 8:2003;566-567
17. Strausberg R.L., Schreiber S.L. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science. 300:2003;294-295
18. Golebiowski A., Klopfenstein S.R., Portlock D.E. Lead compounds discovered from libraries: part 2. Curr Opin Chem Biol. 7:2003;308-325 A comprehensive review of lead compounds with the potential to progress to viable drug candidates identified from combinatorial libraries.
19. Dolle R.E. Comprehensive survey of combinatorial library synthesis: 2002. J Comb Chem. 5:2003;693-753
20. Bleicher K.H., Bohm H.J., Muller K., Alanine A.I. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov. 2:2003;369-378 A comprehensive review describing the current methods of transformation of initial hits into high-content lead series.
21. Rose S., Stevens A. Computational design strategies for combinatorial libraries. Curr Opin Chem Biol. 7:2003;331-339
22. Lengauer T., Lemmen C., Rarey M., Zimmermann M. Novel technologies for virtual screening. Drug Discov Today. 9:2004;27-34
23. Krumrine J., Raubacher F., Brooijmans N., Kuntz I. Principles and methods of docking and ligand design. Methods Biochem Anal. 44:2003;443-476
24. Muller G. Medicinal chemistry of target family-directed masterkeys. Drug Discov Today. 8:2003;681-691 This review focuses on multipurpose privileged structures that address a variety of targets from a gene family of interest, irrespective of therapeutic area.
25. Bondensgaard K., Ankersen M., Thogersen H., Hansen B.S., Wulff B.S., Bywater R.P. Recognition of privileged structures by g-protein coupled receptors. J Med Chem. 47:2004;888-899 An important work demonstrating the correlation between conservation patterns of residues in GPCR ligand binding pocket and the privileged structural fragments.
26. Olesen P.H. The use of bioisosteric groups in lead optimization. Curr Opin Drug Discov Devel. 4:2001;471-478
27. Xue L., Godden J.W., Bajorath J. Mini-fingerprints for virtual screening: design principles and generation of novel prototypes based on information theory. SAR QSAR Environ Res. 14:2003;27-40
28. Merlot C., Domine D., Cleva C., Church D.J. Chemical substructures in drug discovery. Drug Discov Today. 8:2003;594-602
29. van Drie J.H. Pharmacophore discovery-lessons learned. Curr Pharm Des. 9:2003;1649-1664
30. Cramer R.D., Jilek R.J., Andrews K.M. Dbtop: topomer similarity searching of conventional structure databases. J Mol Graph Model. 20:2002;447-462
31. Makara G.M., Nash H., Zheng Z., Orminati J.P., Wintner E.A. A reagent-based strategy for the design of large combinatorial libraries: a preliminary experimental validation. Mol Divers. 7:2003;3-14
32. Jamois E.A. Reagent-based and product-based computational approaches in library design. Curr Opin Chem Biol. 7:2003;326-330
33. Viswanadhan V.N., Balan C., Hulme C., Cheetham J.C., Sun Y. Knowledge-based approaches in the design and selection of compound libraries for drug discovery. Curr Opin Drug Discov Devel. 5:2002;400-406
34. Stockfisch T.P. Partially unified multiple property recursive partitioning (PUMP-RP): a new method for predicting and understanding drug selectivity. J Chem Inf Comput Sci. 43:2003;1608-1613 The authors demonstrate how data from an older, well-studied target can be used to study a newer target for which only a small amount of data are available.
35. Balakin K.V., Lang S.A., Skorenko A.V., Tkachenko S.E., Ivashchenko A.A., Savchuk N.P. Structure-based versus property-based approaches in the design of G-protein-coupled receptor-targeted libraries. J Chem Inf Comput Sci. 43:2003;1553-1562
36. Manallack D.T., Pitt W.R., Gancia E., Montana J.G., Livingstone D.J., Ford M.G., Whitley D.C. Selecting screening candidates for kinase and G-protein coupled receptor targets using neural networks. J Chem Inf Comput Sci. 42:2002;1256-1262
37. Schneider G., Nettekoven M. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps. J Comb Chem. 5:2003;233-237 An interesting example demonstrating the possibility to design a small, activity-enriched focused library with an improved property profile using a virtual screening approach based on Kohonen maps.
38. Balakin K. Pharma ex machina. Mod Drug Disc. 8:2003;45-47
39. Zernov V.V., Balakin K.V., Ivaschenko A.A., Savchuk N.P., Pletnev I.V. Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions. J Chem Inf Comput Sci. 43:2003;2048-2056
40. Oprea T.I. Current trends in lead discovery: Are we looking for the appropriate properties? J Comp-Aid Drug Des. 16:2002;325-334
41. Oprea T.I. Virtual screening in lead discovery: a viewpoint. Mol. 7:2002;51-62
42. Zamora I., Oprea T., Cruciani G., Pastor M., Ungell A.-L. Surface descriptors for protein-ligand affinity prediction. J Med Chem. 46:2003;25-33
43. ter Haar E., Walters W.P., Pazhanisamy S., Taslimi P., Pierce A.C., Bemis G.W., Salituro F.G., Harbeson S. Kinase chemogenomics: targeting the human kinome for target validation and drug discovery. Mini Rev Med Chem. 4:2004;235-253
44. Fradera X., Mestres J. Guided docking approaches to structure-based design and screening. Curr Top Med Chem. 4:2004;687-700